Nanocopoeia, an Innovative Leader in Particle-Based Therapeutics, is Pleased to Announce the Launch of Its Newly Redesigned Website
Summary
Press Releases Nanocopoeia, Inc Press Release Receive press releases from Nanocopoeia, Inc: By Email RSS Feeds: Nanocopoeia, an Innovative Leader in Particle-Based Therapeutics, is Pleased to Announce the Launch of Its Newly Redesigned Website St. Paul, MN, June 01, 2012 --( “We are very excited to showcase our unique capabilities with this new website,” stated Karen Arnold co-founder and CEO, "We turn nanoparticles into a business by identifying therapeutic and industrial uses for those particles.On the therapeutic side, the potential benefit of drugs that are formulated into nanoparticles include 10-fold or greater improvements in bioavailability, increased speed of action, and the possibility of new, more convenient delivery routes when compared with traditional oral or intravenous administration.On the therapeutic side, the potential benefit of drugs that are formulated into nanoparticles include 10-fold or greater improvements in bioavailability, increased speed of action, and the possibility of new, more convenient delivery routes when compared with traditional oral or intravenous administration.The patented ElectroNanospray™ (ENS) process is currently being used to produce complex coatings for medical devices and to nanoformulate drugs.The ENS process consistently results in multiple-fold improvements in water solubility, or more precisely, “nanoscale suspendability.” ENS is used to create either bare drug nanoparticles or coated, core:shell nanoparticles in a single, “bottom up” processing step rather than a multi-step “top down” process.ContactFor further information, please contact Jane Nichols, Director of Business Development at 651-209-1184Nanocopoeia, Inc.1246 W. University AvenueSt.